| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/30/1993 | CA1315471C Pyridine-2,4- and 2,5-dicarboxylic acid derivatives, a process for their preparation, the use thereof, and medicaments based on these compounds |
| 03/30/1993 | CA1315287C Substituted bis-(4-aminophenyl)-sulfones, their preparation and their use as pharmaceutical compositions |
| 03/30/1993 | CA1315283C Tricyclic amines derived from tetrahydro-5,6,7,8, naphto ¬2,3b| dihydro-2,3-furane and tetrahydro-6,7,8,9-5h benzocyclohepta(2,3b) dihydro-2,3-furane, processes for their preparation and pharmaceutical compositions holding same |
| 03/30/1993 | CA1315280C Nitrogenous heterocyclic compounds with antifungus action |
| 03/30/1993 | CA1315279C Anti-inflammatory agents |
| 03/30/1993 | CA1315278C N-(vinblastinoyl-23) derivatives of amino-methylphosphonic acid, processes for their preparation and pharmaceutical compositions containing them |
| 03/30/1993 | CA1315276C Castanospermine esters and glycosides |
| 03/30/1993 | CA1315274C Process for the preparation of new oxime derivatives of 3-substituted 7-aminothiazolylacetamidocephalosporanic acid |
| 03/30/1993 | CA1315230C Antibiotics, process for their preparation and pharmaceutical compositions containing them |
| 03/30/1993 | CA1315223C Method for mutagenesis by oligonucleotide-directed repair of a strand break |
| 03/30/1993 | CA1315202C Oral sustained release acetaminophen formulation and process |
| 03/30/1993 | CA1315201C Pharmaceutical compounds based on benzamido aromatic compounds |
| 03/30/1993 | CA1315149C Process for the preparation of a sterilised casein-based liquid composition |
| 03/28/1993 | CA2079185A1 Dicyclic nitrogens derivatives, preparation process thereof and pharmaceutical compositions containing them |
| 03/28/1993 | CA2079162A1 N-alkyl-3-phenyl-3-(2-halo-substituted phenoxy) propylamines |
| 03/28/1993 | CA2079153A1 14-hydroxy-n-(2-methoxyethyl)-7, 8-dihydromorphine and - norisomorphine, processes for the preparation thereof and the use thereof as pharmaceutical compositions |
| 03/28/1993 | CA2079078A1 Antifungal agent |
| 03/28/1993 | CA2078401A1 Tricyclic heterocycles |
| 03/27/1993 | CA2079042A1 Combination containing growth factors and polyelectrolytes |
| 03/27/1993 | CA2078730A1 Composition for nail treatment containing a sulphur amino acid |
| 03/27/1993 | CA2078699A1 3,6-disubstituted pyridazine derivatives |
| 03/27/1993 | CA2078470A1 Benzylamine derivatives and drugs containing these |
| 03/27/1993 | CA2075453A1 Kedarcidin antitumor chromophore |
| 03/26/1993 | CA2079079A1 Quinazolinones and pyridopyrimidinones |
| 03/26/1993 | CA2079016A1 Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them |
| 03/26/1993 | CA2078901A1 Method for treating hypertension |
| 03/26/1993 | CA2077309A1 Polymeric carriers for release of covalently linked agents |
| 03/25/1993 | DE4131579A1 Thiadiazolo(4,3-a)pyridinderivate, verfahren zu ihrer herstellung und diese enthaltenden arzneimittel Thiadiazolo (4,3-a) pyridine derivatives, process for their production and containing this drug |
| 03/25/1993 | CA2078810A1 Leukotriene biosynthesis inhibitors |
| 03/24/1993 | EP0533639A1 Pharmaceutical product comprising a parci-symphatic-mimetic drug having therapeutic properties on the human sensibility and autocinesis in general |
| 03/24/1993 | EP0533579A1 Trimetazidine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/24/1993 | EP0533573A2 Derivatives of 3-cyclo alkyl-propen-2-amide, their tautomeres and salts and their use as antiinflammatory agents |
| 03/24/1993 | EP0533518A1 Pharmaceutical composition for topical application containing dithranol and process for its preparation |
| 03/24/1993 | EP0533517A1 LPS-containing anti-withdrawal agents |
| 03/24/1993 | EP0533516A2 Amides of 1-(alkoxybenzyl)piperazines, processes for their preparation and pharmaceutical compositions containing them |
| 03/24/1993 | EP0533504A1 Dihydropyridine derivatives useful in antitumor therapy |
| 03/24/1993 | EP0533433A1 Use of rapamycin for the manufacture of a medicament for the treatment of immunoinflammatory diseases |
| 03/24/1993 | EP0533410A1 Method of administering dipalmitoyl/phosphatidylcholine dispersions |
| 03/24/1993 | EP0533352A2 Gaba receptor agonists to treat bladder instability |
| 03/24/1993 | EP0533344A1 Methanoanthracenes as dopamine antagonists |
| 03/24/1993 | EP0533342A1 Anti-HIV (AIDS) agents |
| 03/24/1993 | EP0533281A1 The use of ranitidine bismuth citrate and one or more heliocobacte pylon-inhibiting antibiotics with manufacture of a medicament for treating gastrointestinal disorders |
| 03/24/1993 | EP0533280A1 Novel medical use for tachykinin antagonists |
| 03/24/1993 | EP0533268A1 Benzanilide derivatives as 5-HT1D antagonists |
| 03/24/1993 | EP0533267A1 Benzanilide derivatives as 5-HT1D antagonists |
| 03/24/1993 | EP0533266A1 Benzanilide derivatives as 5-HT1D antagonists |
| 03/24/1993 | EP0533264A1 Process for the preparation of anti-ulcer agents |
| 03/24/1993 | EP0533244A1 Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
| 03/24/1993 | EP0533243A1 Hydantoin and succinimide-substituted spiroindanylcamphorsulfonyl derivatives |
| 03/24/1993 | EP0533242A2 Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
| 03/24/1993 | EP0533241A2 Substituted alkyl derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
| 03/24/1993 | EP0533240A2 Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
| 03/24/1993 | EP0533213A1 Use of azelastin and glycerine ethers for the treatment of psoriasis |
| 03/24/1993 | EP0533149A1 Production of crystalline penem |
| 03/24/1993 | EP0533130A1 2-Hydroxymethylpyridines, the corresponding pyridine-N-oxides and derivatives thereof, process for their preparation and their use |
| 03/24/1993 | EP0533103A1 Production of beta-form thiamine hydrochloride crystals |
| 03/24/1993 | EP0533058A1 Imidazo-fused iso- and heterocycles as angiotensin II antagonists |
| 03/24/1993 | EP0533056A2 Substituted aminopropanes, process for their preparation and their use as antimycotic agents |
| 03/24/1993 | EP0533047A1 Preparation of a cephalosporin antibiotic using the synisomer of a thiazolyl intermediate |
| 03/24/1993 | EP0533014A1 Indolesulfonamide substituted dihydropyridines, process for their preparation and drugs containing them |
| 03/24/1993 | EP0532915A2 Phosphoinositolglycan-peptide with insulin like activity |
| 03/24/1993 | EP0532900A1 The use of nimesulide in the treatment of cataract |
| 03/24/1993 | EP0532878A2 Process for producing acyclic nucleosides |
| 03/24/1993 | EP0532862A1 Use of rapamycin for the preparation of a medicament for the treatment of ocular inflammation |
| 03/24/1993 | EP0532807A1 Saccharide for supplementing energy to living body, and uses thereof |
| 03/24/1993 | EP0532752A1 Compound tan-1251, its derivatives, their production and use |
| 03/24/1993 | EP0532693A1 1,4-diamino-2,3-dihydroxybutanes |
| 03/24/1993 | EP0532674A1 Leukotriene antagonists |
| 03/24/1993 | EP0532642A1 Substituted guanidines having high binding to the sigma receptor and the use thereof |
| 03/24/1993 | EP0532636A1 Bis-naphthalimides as anticancer agents |
| 03/24/1993 | EP0532634A1 Phthalamic acids and their isomers for treating leukotriene-related diseases |
| 03/24/1993 | EP0532621A1 Amide linked pyridyle-benzoic acid derivatives for treating leukotriene-related diseases |
| 03/24/1993 | EP0532602A1 Benzothiazoline derivatives, process for their preparation and drugs containing same. |
| 03/24/1993 | EP0532550A1 Benzoic acid derivatives for treating leukotriene-related diseases |
| 03/24/1993 | EP0532545A1 Nicotinylalanine as a therapeutic agent acting on the central nervous system |
| 03/24/1993 | EP0532531A1 Phenol and pyridinol derivatives as pharmaceuticals |
| 03/24/1993 | EP0532530A1 Derivatives of 6-aminooctahydroindolizinetriol. |
| 03/24/1993 | EP0532525A1 New protein-polycation conjugates. |
| 03/24/1993 | EP0504290A4 Inhibitors of pneumocystis carinii dihydrofolate reductase |
| 03/24/1993 | EP0376959B1 Platinum pharmaceuticals |
| 03/24/1993 | EP0348509B1 Anti-retroviral drug |
| 03/24/1993 | EP0324791B1 Aryl-n-aminoalkyl-4-(sulfonamido)benzamides, antiarrhytmic agents and compositions thereof |
| 03/24/1993 | EP0312612B1 Nutritive emulsion |
| 03/24/1993 | EP0211894B1 Fsh |
| 03/24/1993 | CN1070192A Macrolide antibiotics and their preparation |
| 03/24/1993 | CN1070191A 1,3-oxathiolane nucleoside analogues |
| 03/24/1993 | CN1070190A Heterocyclically substituted quinolylmethoxy-phenylacetamides |
| 03/24/1993 | CN1070108A Prescription and preparing process for finger or toe nail tinea paster |
| 03/24/1993 | CN1070083A Microbicide compositions containing iodide |
| 03/24/1993 | CA2078712A1 Composition comprising amino acids for the prevention of hypoxic damage and a process for its preparation |
| 03/23/1993 | US5196570 Leukotriene-b4 derivatives, process for their production and their use as pharmaceutical agents |
| 03/23/1993 | US5196533 Cyclization of 5 amino-pyrimidines to quinoid 6,6 disubstituted dihydropteridines |
| 03/23/1993 | US5196528 4-cyclohexenyl azetidinones and epoxy derivatives thereof |
| 03/23/1993 | US5196522 Anthracycline analogues bearing latent alkylating substituents |
| 03/23/1993 | US5196454 Method of treating disorders of the dopaminergic systems using 2,5-diaminotetralines |
| 03/23/1993 | US5196453 Antitumor, immunosuppressive |
| 03/23/1993 | US5196452 Macrocyclic anti-viral compound and method |
| 03/23/1993 | US5196450 Method of inhibiting protozoal growth |
| 03/23/1993 | US5196449 Vision defects |
| 03/23/1993 | US5196448 Applying silybin derivative to skin |